NCT05109312 - A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions

Analgesia

Interventions

DRUG

Bupivacaine Hydrochloride

100 mg

DRUG

Bupivacaine Hydrochloride

125 mg

DRUG

HTX-011

400 mg

DEVICE

Luer lock applicator

Applicator for instillation

DRUG

Ibuprofen

400 mg

DRUG

Acetaminophen

1 g

Trial Locations (7)

Gulfcoast Research Institute, Sarasota

Woodland International Research Group, LLC, Little Rock

The Orthopaedic Center, Tulsa

Legent Orthopedic Hospital, Carrollton

First Surgical Hospital, Bellaire

Endeavor Clinical Trials, LLC, San Antonio

JBR Clinical Research, Salt Lake City